BIOX
Bioceres Crop·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 0
Bearish signal 5
MACD Death Cross
Bearish Engulfing
Significant Net Income Decline
Low Cash Short-term Debt Ratio
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BIOX
Bioceres Crop Solutions Corp.
A company that provides crop productivity solutions including seeds, biologicals, and fertilizers
Ocampo 210 bis, Predio CCT, Rosario, Province of Santa Fe, Argentina
--
Bioceres Crop Solutions Corp. was incorporated in the Cayman Islands on November 14, 2017, with its principal executive office in Rosario, Argentina. The Company owns and operates manufacturing and distribution facilities in Pergamino (Argentina), Bangor (Michigan, USA) and Londrina (Brazil), and has R&D centers in Pergamino, Davis (California) and Helsinki (Finland). Bioceres also has sales offices or subsidiaries in 11 countries. As a leader in agricultural biotechnology, Bioceres develops and commercializes productivity solutions to regenerate agroecosystems and enhance crop resilience to climate change, creating economic incentives for sustainable agricultural practices. Its biotechnology platform integrates patented technologies in seeds, microbial inputs, crop nutrition and protection solutions, and its business activities are divided into crop protection, seeds and integrated products, and crop nutrition segments. The company's products are sold in more than 45 countries, mainly in South America, the United States and Europe.
Earnings Call
Q3/2025
Estimate EPS-0.1
Actual EPS-0.02
Estimate Revenue61.87M
Actual Revenue60.60M
Bioceres' Q3 2025 Earnings Call: Contradictions in Argentina's Market Sentiment and U.S. Interest Rates
May 21,2025 12:15
Earnings Decrypt
Earnings Decrypt
Q4/2025
Estimate EPS0.09
Actual EPS-0.12
Estimate Revenue110.08M
Actual Revenue77.50M
Bioceres Crop Solutions' Q4 2025 Earnings Call Contradictions: Cash Flow, Cost Savings, RinoTec, Syngenta, and Strategic Priorities Clash
Sep 09,2025 12:51
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
BIOX has released its 2025 Q4 earnings. EPS was reported at -0.12, versus the expected 0.09, missing expectations. The chart below visualizes how BIOX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BIOX has released its 2026 Q1 earnings report, with revenue of 77.60M, reflecting a YoY change of -16.82%, and net profit of -7.45M, showing a YoY change of -20.17%. The Sankey diagram below clearly presents BIOX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
